CD4 Effectors Need to Recognize Antigen Locally to Become Cytotoxic CD4 and Follicular Helper T Cells [preprint]
Authors
Devarajan, PriyadharshiniVong, Allen M.
Castonguay, Catherine H.
Bautista, Bianca L.
Jones, Michael C.
Kugler-Umana, Olivia
Kelly, Karen A.
Swain, Susan L
UMass Chan Affiliations
Graduate School of Biomedical SciencesDepartment of Animal Medicine
Department of Pathology
Document Type
PreprintPublication Date
2020-09-03Keywords
ImmunologyInfluenza
Cytotoxic CD4
vaccine design
antigens
Immunology of Infectious Disease
Immunopathology
Immunoprophylaxis and Therapy
Immunotherapy
Metadata
Show full item recordAbstract
T follicular helper (TFH) and Cytotoxic CD4 (ThCTL) are tissue-restricted CD4 effector subsets, functionally specialized to mediate optimal Ab production and cytotoxicity of infected cells. Influenza infection generates robust CD4 responses, including lung ThCTL and SLO TFH, that protect against reinfection by variant strains. Antigen (Ag) presentation after infection, lasts through the effector phase of the response. Here, we show that this effector phase Ag presentation, well after priming, is required to drive CD4 effectors to ThCTL and TFH. Using in vivo influenza models, we varied Ag presentation to effectors acutely, just at the effector phase. Ag presentation was required in the tissue of effector residence. We suggest these requirements contain unnecessary or potentially pathogenic CD4 responses, only allowing them if infection is uncleared. The results imply that providing effector phase Ag, would lead to stronger humoral and CD4 tissue immunity and thus can be applied to improve vaccine design.Source
bioRxiv 2020.09.03.281998; doi: https://doi.org/10.1101/2020.09.03.281998. Link to preprint on bioRxiv
DOI
10.1101/2020.09.03.281998Permanent Link to this Item
http://hdl.handle.net/20.500.14038/29601Notes
This article is a preprint. Preprints are preliminary reports of work that have not been certified by peer review.
Related Resources
Now published in Cell Reports doi: 10.1016/j.celrep.2023.113182Rights
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.Distribution License
http://creativecommons.org/licenses/by-nc-nd/4.0/ae974a485f413a2113503eed53cd6c53
10.1101/2020.09.03.281998
Scopus Count
Except where otherwise noted, this item's license is described as The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.